Key facts
- It has raised $8.5M; the latest was Seed Round ($8.5M) in May 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Geviti
- ·The full record, as it builds
Funding rounds
No funding rounds for Geviti are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Geviti
Operator of a telehealth company intended to support personalized longevity care through proactive, data-driven methodologies. The company offers advanced at-home blood testing, AI-powered health analysis, custom supplement protocols, and expert clinical guidance, providing individuals with the ability to monitor and optimize their health, detect potential risks before they arise, and access preventative care strategies designed to enhance long-term well-being and overall lifespan.
- Sector
- Healthcare
- HQ
- Gilbert, AZ, United States
- Founded
- 2021
- Employees
- 19
- Website
- gogeviti.com/
- Ownership
- Privately Held (backing)
Geviti doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Geviti shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Geviti in its N-PORT filings yet. We sweep new filings monthly.